Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni
Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than 200 million people requiring preventive treatment. As praziquantel (PZQ) remains the treatment of choice, an urgent need for alternative trea...
Uloženo v:
| Vydáno v: | International journal for parasitology -- drugs and drug resistance Ročník 13; s. 73 - 88 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Elsevier Ltd
01.08.2020
Elsevier |
| Témata: | |
| ISSN: | 2211-3207, 2211-3207 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than 200 million people requiring preventive treatment. As praziquantel (PZQ) remains the treatment of choice, an urgent need for alternative treatments motivates research to identify new lead compounds that would complement PZQ by filling the therapeutic gaps associated with this treatment. Because impairing parasite neurotransmission remains a core strategy for control of parasitic helminths, we screened a library of 708 compounds with validated biological activity in humans on the blood fluke Schistosoma mansoni, measuring their effect on the motility on schistosomulae and adult worms. The primary phenotypic screen performed on schistosomulae identified 70 compounds that induced changes in viability and/or motility. Screening different concentrations and incubation times identified molecules with fast onset of activity on both life stages at low concentration (1 μM). To complement this study, similar assays were performed with chemical analogs of the cholinomimetic drug arecoline and the calcilytic molecule NPS-2143, two compounds that rapidly inhibited schistosome motility; 17 arecoline and 302 NPS-2143 analogs were tested to enlarge the pool of schistosomicidal molecules. Finally, validated hit compounds were tested on three functionally-validated neuroregulatory S. mansoni G-protein coupled receptors (GPCRs): Sm5HTR (serotonin-sensitive), SmGPR2 (histamine) and SmD2 (dopamine), revealing NPS-2143 and analogs as potent inhibitors of dopamine/epinine responses on both human and S. mansoni GPCRs. This study highlights the potential for repurposing known human therapeutic agents for potential schistosomicidal effects and expands the list of hits for further progression.
[Display omitted]
•Screening annotated bioactive molecules to ease new treatment search.•Coupling motility recording of treated parasite and molecular target search.•Exploiting chemical analogs to expand bioactive compound search.•The larvicidal NPS-2143 acts on dopaminergic GPCRs. |
|---|---|
| AbstractList | Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than 200 million people requiring preventive treatment. As praziquantel (PZQ) remains the treatment of choice, an urgent need for alternative treatments motivates research to identify new lead compounds that would complement PZQ by filling the therapeutic gaps associated with this treatment. Because impairing parasite neurotransmission remains a core strategy for control of parasitic helminths, we screened a library of 708 compounds with validated biological activity in humans on the blood fluke Schistosoma mansoni, measuring their effect on the motility on schistosomulae and adult worms. The primary phenotypic screen performed on schistosomulae identified 70 compounds that induced changes in viability and/or motility. Screening different concentrations and incubation times identified molecules with fast onset of activity on both life stages at low concentration (1 μM). To complement this study, similar assays were performed with chemical analogs of the cholinomimetic drug arecoline and the calcilytic molecule NPS-2143, two compounds that rapidly inhibited schistosome motility; 17 arecoline and 302 NPS-2143 analogs were tested to enlarge the pool of schistosomicidal molecules. Finally, validated hit compounds were tested on three functionally-validated neuroregulatory S. mansoni G-protein coupled receptors (GPCRs): Sm5HTR (serotonin-sensitive), SmGPR2 (histamine) and SmD2 (dopamine), revealing NPS-2143 and analogs as potent inhibitors of dopamine/epinine responses on both human and S. mansoni GPCRs. This study highlights the potential for repurposing known human therapeutic agents for potential schistosomicidal effects and expands the list of hits for further progression.
Image 1
•
Screening annotated bioactive molecules to ease new treatment search.
•
Coupling motility recording of treated parasite and molecular target search.
•
Exploiting chemical analogs to expand bioactive compound search.
•
The larvicidal NPS-2143 acts on dopaminergic GPCRs. Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than 200 million people requiring preventive treatment. As praziquantel (PZQ) remains the treatment of choice, an urgent need for alternative treatments motivates research to identify new lead compounds that would complement PZQ by filling the therapeutic gaps associated with this treatment. Because impairing parasite neurotransmission remains a core strategy for control of parasitic helminths, we screened a library of 708 compounds with validated biological activity in humans on the blood fluke Schistosoma mansoni, measuring their effect on the motility on schistosomulae and adult worms. The primary phenotypic screen performed on schistosomulae identified 70 compounds that induced changes in viability and/or motility. Screening different concentrations and incubation times identified molecules with fast onset of activity on both life stages at low concentration (1 μM). To complement this study, similar assays were performed with chemical analogs of the cholinomimetic drug arecoline and the calcilytic molecule NPS-2143, two compounds that rapidly inhibited schistosome motility; 17 arecoline and 302 NPS-2143 analogs were tested to enlarge the pool of schistosomicidal molecules. Finally, validated hit compounds were tested on three functionally-validated neuroregulatory S. mansoni G-protein coupled receptors (GPCRs): Sm5HTR (serotonin-sensitive), SmGPR2 (histamine) and SmD2 (dopamine), revealing NPS-2143 and analogs as potent inhibitors of dopamine/epinine responses on both human and S. mansoni GPCRs. This study highlights the potential for repurposing known human therapeutic agents for potential schistosomicidal effects and expands the list of hits for further progression. Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than 200 million people requiring preventive treatment. As praziquantel (PZQ) remains the treatment of choice, an urgent need for alternative treatments motivates research to identify new lead compounds that would complement PZQ by filling the therapeutic gaps associated with this treatment. Because impairing parasite neurotransmission remains a core strategy for control of parasitic helminths, we screened a library of 708 compounds with validated biological activity in humans on the blood fluke Schistosoma mansoni, measuring their effect on the motility on schistosomulae and adult worms. The primary phenotypic screen performed on schistosomulae identified 70 compounds that induced changes in viability and/or motility. Screening different concentrations and incubation times identified molecules with fast onset of activity on both life stages at low concentration (1 μM). To complement this study, similar assays were performed with chemical analogs of the cholinomimetic drug arecoline and the calcilytic molecule NPS-2143, two compounds that rapidly inhibited schistosome motility; 17 arecoline and 302 NPS-2143 analogs were tested to enlarge the pool of schistosomicidal molecules. Finally, validated hit compounds were tested on three functionally-validated neuroregulatory S. mansoni G-protein coupled receptors (GPCRs): Sm5HTR (serotonin-sensitive), SmGPR2 (histamine) and SmD2 (dopamine), revealing NPS-2143 and analogs as potent inhibitors of dopamine/epinine responses on both human and S. mansoni GPCRs. This study highlights the potential for repurposing known human therapeutic agents for potential schistosomicidal effects and expands the list of hits for further progression. [Display omitted] •Screening annotated bioactive molecules to ease new treatment search.•Coupling motility recording of treated parasite and molecular target search.•Exploiting chemical analogs to expand bioactive compound search.•The larvicidal NPS-2143 acts on dopaminergic GPCRs. Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than 200 million people requiring preventive treatment. As praziquantel (PZQ) remains the treatment of choice, an urgent need for alternative treatments motivates research to identify new lead compounds that would complement PZQ by filling the therapeutic gaps associated with this treatment. Because impairing parasite neurotransmission remains a core strategy for control of parasitic helminths, we screened a library of 708 compounds with validated biological activity in humans on the blood fluke Schistosoma mansoni, measuring their effect on the motility on schistosomulae and adult worms. The primary phenotypic screen performed on schistosomulae identified 70 compounds that induced changes in viability and/or motility. Screening different concentrations and incubation times identified molecules with fast onset of activity on both life stages at low concentration (1 μM). To complement this study, similar assays were performed with chemical analogs of the cholinomimetic drug arecoline and the calcilytic molecule NPS-2143, two compounds that rapidly inhibited schistosome motility; 17 arecoline and 302 NPS-2143 analogs were tested to enlarge the pool of schistosomicidal molecules. Finally, validated hit compounds were tested on three functionally-validated neuroregulatory S. mansoni G-protein coupled receptors (GPCRs): Sm5HTR (serotonin-sensitive), SmGPR2 (histamine) and SmD2 (dopamine), revealing NPS-2143 and analogs as potent inhibitors of dopamine/epinine responses on both human and S. mansoni GPCRs. This study highlights the potential for repurposing known human therapeutic agents for potential schistosomicidal effects and expands the list of hits for further progression.Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than 200 million people requiring preventive treatment. As praziquantel (PZQ) remains the treatment of choice, an urgent need for alternative treatments motivates research to identify new lead compounds that would complement PZQ by filling the therapeutic gaps associated with this treatment. Because impairing parasite neurotransmission remains a core strategy for control of parasitic helminths, we screened a library of 708 compounds with validated biological activity in humans on the blood fluke Schistosoma mansoni, measuring their effect on the motility on schistosomulae and adult worms. The primary phenotypic screen performed on schistosomulae identified 70 compounds that induced changes in viability and/or motility. Screening different concentrations and incubation times identified molecules with fast onset of activity on both life stages at low concentration (1 μM). To complement this study, similar assays were performed with chemical analogs of the cholinomimetic drug arecoline and the calcilytic molecule NPS-2143, two compounds that rapidly inhibited schistosome motility; 17 arecoline and 302 NPS-2143 analogs were tested to enlarge the pool of schistosomicidal molecules. Finally, validated hit compounds were tested on three functionally-validated neuroregulatory S. mansoni G-protein coupled receptors (GPCRs): Sm5HTR (serotonin-sensitive), SmGPR2 (histamine) and SmD2 (dopamine), revealing NPS-2143 and analogs as potent inhibitors of dopamine/epinine responses on both human and S. mansoni GPCRs. This study highlights the potential for repurposing known human therapeutic agents for potential schistosomicidal effects and expands the list of hits for further progression. |
| Author | Mochalkin, Igor Kulkarni, Shashank Rashid, Mohammed Ribeiro, Paula Geary, Timothy G. Glebov, Anastasia Hussain, Asimah Spangenberg, Thomas Duguet, Thomas B. |
| Author_xml | – sequence: 1 givenname: Thomas B. surname: Duguet fullname: Duguet, Thomas B. email: thomas.duguet@mail.mcgill.ca organization: Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada – sequence: 2 givenname: Anastasia surname: Glebov fullname: Glebov, Anastasia organization: Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada – sequence: 3 givenname: Asimah surname: Hussain fullname: Hussain, Asimah organization: Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada – sequence: 4 givenname: Shashank surname: Kulkarni fullname: Kulkarni, Shashank organization: EMD Serono Research and Development Institute, Billerica, MA, USA – sequence: 5 givenname: Igor surname: Mochalkin fullname: Mochalkin, Igor organization: EMD Serono Research and Development Institute, Billerica, MA, USA – sequence: 6 givenname: Timothy G. surname: Geary fullname: Geary, Timothy G. organization: Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada – sequence: 7 givenname: Mohammed surname: Rashid fullname: Rashid, Mohammed organization: Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada – sequence: 8 givenname: Thomas orcidid: 0000-0002-5654-8919 surname: Spangenberg fullname: Spangenberg, Thomas email: thomas.spangenberg@merckgroup.com organization: Global Health Institute of Merck, Ares Trading S.A., a subsidiary of Merck KGaA (Darmstadt, Germany), Eysins, Switzerland – sequence: 9 givenname: Paula surname: Ribeiro fullname: Ribeiro, Paula organization: Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32531750$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUk1vEzEQtVARLaH_AKE9ckmwvev94ICEKj4iVeIAnC1_zDaz9drBdiL13-M0oWo5gC8ejd97Y715L8mZDx4Iec3oilHWvptWOG2tjStOOV1RsaKUPyMXnDO2rDntzh7V5-QypYmW01LWM_qCnNdc1KwT9ILcri34jCMalTH4KoyV8j5klcFWGoMyGfdQzcGB2TlIVd6oXOG8VRhLN6PDfHdg5Q1U2oVgq9HtbqH6bjaYckhhVtWsfAoeX5Hno3IJLk_3gvz8_OnH1dfl9bcv66uP10sj-JCXumuN0lSNuh9rOraNqseOKwUD5dbSVhvDBz42THBq637oYRBa8Fb3tBRa1wuyPuraoCa5jTireCeDQnnfCPFGqpjROJAKRKc7Ubdd0zZlhra94D10FLqurZkqWh-OWtudnsGaYlZU7ono0xePG3kT9rLjfcOKzQvy9iQQw68dpCxnTAacUx7CLkleUMPQsKYv0DePZz0M-bOtAmiOABNDShHGBwij8pALOcljLuQhF5IKWXJRaO__ohnM9-suP0b3P_LJACgb2yNEmQyCN2AxgsnFUvy3wG-2ndgO |
| CitedBy_id | crossref_primary_10_1038_s42003_023_05675_4 crossref_primary_10_1371_journal_pntd_0009432 crossref_primary_10_1080_14656566_2024_2333372 crossref_primary_10_1016_j_drudis_2022_04_004 crossref_primary_10_3389_fphar_2022_872212 crossref_primary_10_1016_j_pt_2021_05_004 crossref_primary_10_3389_fimmu_2021_642383 |
| Cites_doi | 10.1007/BF00389899 10.1186/s40249-015-0071-z 10.1126/science.1243106 10.1111/febs.14029 10.1007/s004360050227 10.1016/j.ijpara.2010.04.006 10.2174/1568026618666180427145308 10.1371/journal.pntd.0001494 10.2174/0929867325666180926145537 10.1242/dmm.033563 10.1007/s00436-001-0585-0 10.1002/wmts.19 10.1371/journal.pntd.0000478 10.1007/s00436-002-0751-z 10.1038/s41598-018-26532-z 10.1016/0035-9203(73)90039-4 10.1039/C5MD00596E 10.1371/journal.ppat.1003878 10.1016/j.exppara.2007.08.002 10.1371/journal.pntd.0001523 10.1016/S0140-6736(13)61949-2 10.1371/journal.pntd.0003962 10.1139/Z09-126 10.1371/journal.pntd.0002610 10.1371/journal.pntd.0004063 10.1016/j.molbiopara.2008.11.007 10.1371/journal.pntd.0001762 10.1128/AAC.02582-16 10.1371/journal.pntd.0007693 10.1016/0035-9203(87)90282-3 10.4155/fmc.15.26 10.1021/acsinfecdis.9b00237 10.1016/j.exppara.2005.01.002 10.1016/j.molbiopara.2009.06.003 10.7554/eLife.41337 10.1016/j.ijpddr.2018.09.001 10.1074/jbc.AC119.011093 10.1093/jac/dkt491 10.1186/1471-2164-12-14 10.1021/ml3003814 10.1186/s40364-016-0075-2 10.1371/journal.ppat.1005651 10.1074/jbc.C100273200 10.1186/1476-4598-13-42 10.1172/JCI17416 10.1016/j.bmc.2010.09.041 10.1111/j.1476-5381.2011.01511.x 10.1186/s13071-019-3747-6 10.1371/journal.ppat.1004181 10.1016/j.molbiopara.2010.12.001 10.1016/j.molbiopara.2014.06.002 10.7554/eLife.35755 10.1017/S0031182000066270 10.1371/journal.pntd.0000504 10.1038/s41598-017-18457-w 10.1371/journal.ppat.1003942 10.1038/s41596-018-0101-y 10.1155/2016/9521349 10.1186/s13071-017-2293-3 10.1021/acs.jafc.5b03749 10.1111/j.1527-3458.2001.tb00189.x 10.1016/j.molbiopara.2018.09.004 10.1093/bioinformatics/btu831 10.1016/S1473-3099(15)00066-3 10.1016/j.tmaid.2008.06.006 10.1016/S0022-3565(24)29333-2 10.1371/journal.pone.0184192 10.1371/journal.pntd.0004659 10.1002/cmdc.201800572 10.4269/ajtmh.1983.32.83 10.1677/joe.1.06924 10.1016/S0166-6851(01)00400-5 10.4137/EBO.S9405 10.1186/s13071-015-1233-3 10.1016/j.molbiopara.2015.09.001 10.1074/jbc.R112.406280 10.1371/journal.ppat.1003254 10.1016/j.molbiopara.2007.03.010 10.1007/s10158-012-0132-y 10.1111/j.1476-5381.1966.tb01845.x |
| ContentType | Journal Article |
| Copyright | 2020 The Authors Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. 2020 The Authors 2020 |
| Copyright_xml | – notice: 2020 The Authors – notice: Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: 2020 The Authors 2020 |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1016/j.ijpddr.2020.05.002 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2211-3207 |
| EndPage | 88 |
| ExternalDocumentID | oai_doaj_org_article_ae57b753674642aabd8528e70e77631a PMC7284125 32531750 10_1016_j_ijpddr_2020_05_002 S2211320720300129 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K 0R~ 0SF 1~5 457 4G. 5VS 6I. 7-5 AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ADBBV ADEZE AEXQZ AFTJW AGHFR AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HYE HZ~ IPNFZ IXB KQ8 M41 M48 NCXOZ O-L O9- OK1 RIG ROL RPM SSZ XH2 AAYWO AAYXX ADVLN AFJKZ APXCP CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c529t-b76cab0afb8f30f64a3f72aae902dd06bcc292f41520d3898e95b526b8095bbb3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 11 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000556674900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2211-3207 |
| IngestDate | Fri Oct 03 12:41:31 EDT 2025 Tue Sep 30 16:53:08 EDT 2025 Fri Jul 11 07:05:52 EDT 2025 Thu Apr 03 07:08:26 EDT 2025 Wed Nov 05 20:54:49 EST 2025 Tue Nov 18 21:50:52 EST 2025 Wed May 17 01:22:43 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | NPS-2143 Schistosomiasis Screening GPCR Anthelmintic Motility |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c529t-b76cab0afb8f30f64a3f72aae902dd06bcc292f41520d3898e95b526b8095bbb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Current address: Vertex Pharmaceuticals, San Diego, CA, USA. Deceased March 4, 2017. |
| ORCID | 0000-0002-5654-8919 |
| OpenAccessLink | https://doaj.org/article/ae57b753674642aabd8528e70e77631a |
| PMID | 32531750 |
| PQID | 2412994148 |
| PQPubID | 23479 |
| PageCount | 16 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_ae57b753674642aabd8528e70e77631a pubmedcentral_primary_oai_pubmedcentral_nih_gov_7284125 proquest_miscellaneous_2412994148 pubmed_primary_32531750 crossref_primary_10_1016_j_ijpddr_2020_05_002 crossref_citationtrail_10_1016_j_ijpddr_2020_05_002 elsevier_sciencedirect_doi_10_1016_j_ijpddr_2020_05_002 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-08-01 |
| PublicationDateYYYYMMDD | 2020-08-01 |
| PublicationDate_xml | – month: 08 year: 2020 text: 2020-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | International journal for parasitology -- drugs and drug resistance |
| PublicationTitleAlternate | Int J Parasitol Drugs Drug Resist |
| PublicationYear | 2020 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Holden-Dye, Walker (bib32) 2007 Bibo-Verdugo, Wang, Almaliti, Ta, Jiang, Wong, Lietz, Suzuki, El-Sakkary, Hook, Salvesen, Gerwick, Caffrey, O'Donoghue (bib7) 2019; 5 Gold (bib26) 1997; 83 Maccesi, Aguiar, Pasche, Padilla, Suzuki, Montefusco, Abagyan, Keiser, Mourao, Caffrey (bib44) 2019; 12 Chan, Agbedanu, Grab, Zamanian, Dosa, Day, Marchant (bib9) 2015; 9 Nemeth, Delmar, Heaton, Miller, Lambert, Conklin, Gowen, Gleason, Bhatnagar, Fox (bib57) 2001; 299 Van Nassauw, Toovey, Van Op den Bosch, Timmermans, Vercruysse (bib79) 2008; 6 El-Sakkary, Chen, Arkin, Caffrey, Ribeiro (bib19) 2018; 11 Kohn, Anderson, Roberts-Misterly, Greenberg (bib36) 2001; 276 Day, Chen, Miller, Tian, Bennett, Pax (bib16) 1996; 113 Mine, Zhang (bib53) 2015; 63 Li, Ziniel, He, Kommer, Crowther, He, Liu, Van Voorhis, Williams, Wang (bib42) 2015; 4 Kos, Karaplis, Peng, Hediger, Goltzman, Mohammad, Guise, Pollak (bib37) 2003; 111 Ingram-Sieber, Cowan, Panic, Vargas, Mansour, Bickle, Wells, Spangenberg, Keiser (bib33) 2014; 8 Cioli, Pica-Mattoccia, Basso, Guidi (bib14) 2014; 195 Atwood, Lopez, Wager-Miller, Mackie, Straiker (bib4) 2011; 12 Chan, McCorvy, Acharya, Johns, Day, Roth, Marchant (bib12) 2016; 12 Ward, Riccardi (bib80) 2012; 165 Gupta, Aggarwal, Singh, Yadav, Khan (bib29) 2018; 8 El-Shehabi, Taman, Moali, El-Sakkary, Ribeiro (bib21) 2012; 6 El-Shehabi, Ribeiro (bib20) 2010; 40 Kovac, Vargas, Keiser (bib38) 2017; 10 Kuhn, Kellenberger, Said-Hassane, Villa, Rognan, Lobstein, Haiech, Hibert, Schuber, Muller-Steffner (bib39) 2010; 18 Wolstenholme (bib85) 2012; 287 Joeckel, Haber, Prawitt, Junker, Hampel, Thuroff, Roos, Brenner (bib35) 2014; 13 Ribeiro, Geary (bib69) 2009; 88 Taman, Ribeiro (bib73) 2009; 168 Weth, Haeberlein, Haimann, Zhang, Grevelding (bib82) 2019 Gonnert, Andrews (bib27) 1977; 52 Lai, Biedermann, Ekpo, Garba, Mathieu, Midzi, Mwinzi, N'Goran, Raso, Assare, Sacko, Schur, Talla, Tchuente, Toure, Winkler, Utzinger, Vounatsou (bib40) 2015; 15 Barker, Bueding, Timms (bib5) 1966; 26 Colley, Bustinduy, Secor, King (bib15) 2014; 383 Lewis (bib41) 2001 Ittiprasert, Mann, Karinshak, Coghlan, Rinaldi, Sankaranarayanan, Chaidee, Tanno, Kumkhaek, Prangtaworn, Mentink-Kane, Cochran, Driguez, Holroyd, Tracey, Rodpai, Everts, Hokke, Hoffmann, Berriman, Brindley (bib34) 2019; 8 Morais, Oliveira, Paula, Ornelas, Moreira, Badoco, Magalhaes, Verjovski-Almeida, Rodrigues (bib54) 2017; 12 Patocka, Sharma, Rashid, Ribeiro (bib64) 2014; 10 Guerra-Sa, Castro-Borges, Evangelista, Kettelhut, Rodrigues (bib28) 2005; 109 Dosa, Ward, Walters, Kim (bib18) 2013; 4 Bibo-Verdugo, Jiang, Caffrey, O'Donoghue (bib6) 2017; 284 Ribeiro, Gupta, El-Sakkary (bib70) 2012; 12 MacDonald, Buxton, Kimber, Day, Robertson, Ribeiro (bib45) 2014; 10 Park, Gunaratne, Chulkov, Moehring, McCusker, Dosa, Chan, Stucky, Marchant (bib62) 2019; 294 Gemmell (bib25) 1973; 48 Mansour, Paveley, Gardner, Bell, Parkinson, Bickle (bib48) 2016; 10 Tekwu, Anyan, Boamah, Baffour-Awuah, Keyetat Tekwu, Penlap Beng, Nyarko, Bosompem (bib75) 2016; 4 Valentim, Cioli, Chevalier, Cao, Taylor, Holloway, Pica-Mattoccia, Guidi, Basso, Tsai, Berriman, Carvalho-Queiroz, Almeida, Aguilar, Frantz, Hart, LoVerde, Anderson (bib78) 2013; 342 Bourin, Chue, Guillon (bib8) 2001; 7 Neves, Dantas, Senger, Valente, Rezende-Neto, Chaves, Kamentsky, Carpenter, Silva-Junior, Andrade (bib58) 2016; 7 Panic, Vargas, Scandale, Keiser (bib61) 2015; 9 Chan, Agbedanu, Zamanian, Gruba, Haynes, Day, Marchant (bib10) 2014; 10 Eweas, Allam (bib22) 2018; 225 Mellin, Busch, Wang, Kath (bib51) 1983; 32 Whatley, Padalino, Whiteland, Geyer, Hulme, Chalmers, Forde-Thomas, Ferla, Brancale, Hoffmann (bib83) 2019; 13 Foster (bib23) 1987; 81 Rybczynska, Lehmann, Jurska-Jasko, Boblewski, Orlewska, Foks, Drewnowska (bib71) 2006; 191 Hamdan, Mousa, Ribeiro (bib31) 2002; 88 Salvador-Recatala, Greenberg (bib72) 2012; 1 Patocka, Ribeiro (bib63) 2007; 154 Chan, Day, Marchant (bib11) 2018; 7 Hamdan, Abramovitz, Mousa, Xie, Durocher, Ribeiro (bib30) 2002; 119 Lombardo, Pasche, Panic, Endriss, Keiser (bib43) 2019; 14 Nabhan, El-Shehabi, Patocka, Ribeiro (bib55) 2007; 117 Weeks, Roberts, Leasure, Suzuki, Robinson, Currey, Wangchuk, Eichenberger, Saxton, Bird, Kraemer, Loukas, Hawdon, Caffrey, Liachko (bib81) 2018; 8 Foster, Cheetham, King (bib24) 1973; 67 Abdulla, Ruelas, Wolff, Snedecor, Lim, Xu, Renslo, Williams, McKerrow, Caffrey (bib1) 2009; 3 Thomas, Timson (bib76) 2020; 27 Vale, Gouveia, Rinaldi, Brindley, Gartner, Correia da Costa (bib77) 2017; 61 Aragon, Imani, Blackburn, Cupit, Melman, Goronga, Webb, Loker, Cunningham (bib2) 2009; 164 Asarnow, Rojo-Arreola, Suzuki, Caffrey, Singh (bib3) 2015; 31 Ramamoorthi, Graef, Dent (bib67) 2015; 7 Cioli, Pica-Mattoccia (bib13) 2003; 1 Mader, Rennar, Ventura, Grevelding, Schlitzer (bib47) 2018; 13 Marcellino, Gut, Lim, Singh, McKerrow, Sakanari (bib49) 2012; 6 Olliaro, Delgado-Romero, Keiser (bib59) 2014; 69 You, McManus, Hu, Smout, Brindley, Gobert (bib84) 2013; 9 Marchant, Harding, Chan (bib50) 2018; 8 Rashid, MacDonald, Ribeiro (bib68) 2015 Paveley, Mansour, Hallyburton, Bleicher, Benn, Mikic, Guidi, Gilbert, Hopkins, Bickle (bib65) 2012; 6 Nagarathnam, Kalaimathy, Balakrishnan, Sowdhamini (bib56) 2012; 8 MacDonald, Kimber, Day, Ribeiro (bib46) 2015; 202 Taman, Ribeiro (bib74) 2011; 176 Pereira, Curra, Garcia (bib66) 2018; 18 de Almeida, de Carvalho, Gazolla, Silva Pinto, da Silva, de Moraes, Da Silva Filho (bib17) 2016; 2016 Holden-dye, Walker (bib86) 2014 Melman, Steinauer, Cunningham, Kubatko, Mwangi, Wynn, Mutuku, Karanja, Colley, Black, Secor, Mkoji, Loker (bib52) 2009; 3 Panic, Flores, Ingram-Sieber, Keiser (bib60) 2015; 8 El-Shehabi (10.1016/j.ijpddr.2020.05.002_bib21) 2012; 6 Rashid (10.1016/j.ijpddr.2020.05.002_bib68) 2015 Lai (10.1016/j.ijpddr.2020.05.002_bib40) 2015; 15 Lewis (10.1016/j.ijpddr.2020.05.002_bib41) 2001 Melman (10.1016/j.ijpddr.2020.05.002_bib52) 2009; 3 MacDonald (10.1016/j.ijpddr.2020.05.002_bib46) 2015; 202 Kos (10.1016/j.ijpddr.2020.05.002_bib37) 2003; 111 Asarnow (10.1016/j.ijpddr.2020.05.002_bib3) 2015; 31 Holden-dye (10.1016/j.ijpddr.2020.05.002_bib86) 2014 Holden-Dye (10.1016/j.ijpddr.2020.05.002_bib32) 2007 Li (10.1016/j.ijpddr.2020.05.002_bib42) 2015; 4 Ribeiro (10.1016/j.ijpddr.2020.05.002_bib69) 2009; 88 Gemmell (10.1016/j.ijpddr.2020.05.002_bib25) 1973; 48 You (10.1016/j.ijpddr.2020.05.002_bib84) 2013; 9 Vale (10.1016/j.ijpddr.2020.05.002_bib77) 2017; 61 Mader (10.1016/j.ijpddr.2020.05.002_bib47) 2018; 13 Thomas (10.1016/j.ijpddr.2020.05.002_bib76) 2020; 27 de Almeida (10.1016/j.ijpddr.2020.05.002_bib17) 2016; 2016 Weth (10.1016/j.ijpddr.2020.05.002_bib82) 2019 Van Nassauw (10.1016/j.ijpddr.2020.05.002_bib79) 2008; 6 Mine (10.1016/j.ijpddr.2020.05.002_bib53) 2015; 63 Foster (10.1016/j.ijpddr.2020.05.002_bib23) 1987; 81 Mellin (10.1016/j.ijpddr.2020.05.002_bib51) 1983; 32 Ingram-Sieber (10.1016/j.ijpddr.2020.05.002_bib33) 2014; 8 Abdulla (10.1016/j.ijpddr.2020.05.002_bib1) 2009; 3 Gonnert (10.1016/j.ijpddr.2020.05.002_bib27) 1977; 52 Valentim (10.1016/j.ijpddr.2020.05.002_bib78) 2013; 342 Cioli (10.1016/j.ijpddr.2020.05.002_bib13) 2003; 1 Taman (10.1016/j.ijpddr.2020.05.002_bib73) 2009; 168 Gupta (10.1016/j.ijpddr.2020.05.002_bib29) 2018; 8 Marchant (10.1016/j.ijpddr.2020.05.002_bib50) 2018; 8 Hamdan (10.1016/j.ijpddr.2020.05.002_bib30) 2002; 119 Hamdan (10.1016/j.ijpddr.2020.05.002_bib31) 2002; 88 Kohn (10.1016/j.ijpddr.2020.05.002_bib36) 2001; 276 Pereira (10.1016/j.ijpddr.2020.05.002_bib66) 2018; 18 Chan (10.1016/j.ijpddr.2020.05.002_bib12) 2016; 12 El-Shehabi (10.1016/j.ijpddr.2020.05.002_bib20) 2010; 40 Aragon (10.1016/j.ijpddr.2020.05.002_bib2) 2009; 164 Day (10.1016/j.ijpddr.2020.05.002_bib16) 1996; 113 Morais (10.1016/j.ijpddr.2020.05.002_bib54) 2017; 12 Dosa (10.1016/j.ijpddr.2020.05.002_bib18) 2013; 4 Wolstenholme (10.1016/j.ijpddr.2020.05.002_bib85) 2012; 287 Tekwu (10.1016/j.ijpddr.2020.05.002_bib75) 2016; 4 Foster (10.1016/j.ijpddr.2020.05.002_bib24) 1973; 67 Nagarathnam (10.1016/j.ijpddr.2020.05.002_bib56) 2012; 8 Bibo-Verdugo (10.1016/j.ijpddr.2020.05.002_bib6) 2017; 284 Ramamoorthi (10.1016/j.ijpddr.2020.05.002_bib67) 2015; 7 Paveley (10.1016/j.ijpddr.2020.05.002_bib65) 2012; 6 Chan (10.1016/j.ijpddr.2020.05.002_bib10) 2014; 10 Kovac (10.1016/j.ijpddr.2020.05.002_bib38) 2017; 10 MacDonald (10.1016/j.ijpddr.2020.05.002_bib45) 2014; 10 Mansour (10.1016/j.ijpddr.2020.05.002_bib48) 2016; 10 Patocka (10.1016/j.ijpddr.2020.05.002_bib64) 2014; 10 Barker (10.1016/j.ijpddr.2020.05.002_bib5) 1966; 26 Chan (10.1016/j.ijpddr.2020.05.002_bib11) 2018; 7 Panic (10.1016/j.ijpddr.2020.05.002_bib60) 2015; 8 Ribeiro (10.1016/j.ijpddr.2020.05.002_bib70) 2012; 12 Marcellino (10.1016/j.ijpddr.2020.05.002_bib49) 2012; 6 Bibo-Verdugo (10.1016/j.ijpddr.2020.05.002_bib7) 2019; 5 Maccesi (10.1016/j.ijpddr.2020.05.002_bib44) 2019; 12 Guerra-Sa (10.1016/j.ijpddr.2020.05.002_bib28) 2005; 109 Eweas (10.1016/j.ijpddr.2020.05.002_bib22) 2018; 225 Panic (10.1016/j.ijpddr.2020.05.002_bib61) 2015; 9 El-Sakkary (10.1016/j.ijpddr.2020.05.002_bib19) 2018; 11 Cioli (10.1016/j.ijpddr.2020.05.002_bib14) 2014; 195 Salvador-Recatala (10.1016/j.ijpddr.2020.05.002_bib72) 2012; 1 Atwood (10.1016/j.ijpddr.2020.05.002_bib4) 2011; 12 Ittiprasert (10.1016/j.ijpddr.2020.05.002_bib34) 2019; 8 Bourin (10.1016/j.ijpddr.2020.05.002_bib8) 2001; 7 Chan (10.1016/j.ijpddr.2020.05.002_bib9) 2015; 9 Ward (10.1016/j.ijpddr.2020.05.002_bib80) 2012; 165 Nabhan (10.1016/j.ijpddr.2020.05.002_bib55) 2007; 117 Gold (10.1016/j.ijpddr.2020.05.002_bib26) 1997; 83 Olliaro (10.1016/j.ijpddr.2020.05.002_bib59) 2014; 69 Colley (10.1016/j.ijpddr.2020.05.002_bib15) 2014; 383 Kuhn (10.1016/j.ijpddr.2020.05.002_bib39) 2010; 18 Taman (10.1016/j.ijpddr.2020.05.002_bib74) 2011; 176 Nemeth (10.1016/j.ijpddr.2020.05.002_bib57) 2001; 299 Joeckel (10.1016/j.ijpddr.2020.05.002_bib35) 2014; 13 Patocka (10.1016/j.ijpddr.2020.05.002_bib63) 2007; 154 Whatley (10.1016/j.ijpddr.2020.05.002_bib83) 2019; 13 Neves (10.1016/j.ijpddr.2020.05.002_bib58) 2016; 7 Rybczynska (10.1016/j.ijpddr.2020.05.002_bib71) 2006; 191 Lombardo (10.1016/j.ijpddr.2020.05.002_bib43) 2019; 14 Weeks (10.1016/j.ijpddr.2020.05.002_bib81) 2018; 8 Park (10.1016/j.ijpddr.2020.05.002_bib62) 2019; 294 |
| References_xml | – volume: 176 start-page: 42 year: 2011 end-page: 50 ident: bib74 article-title: Glutamate-mediated signaling in publication-title: Mol. Biochem. Parasitol. – volume: 52 start-page: 129 year: 1977 end-page: 150 ident: bib27 article-title: Praziquantel, a new broad-spectrum antischistosomal agent publication-title: Zeitschrift fur Parasitenkunde (Berlin, Germany) – volume: 113 start-page: 55 year: 1996 end-page: 61 ident: bib16 article-title: Cholinergic inhibition of muscle fibres isolated from publication-title: Parasitology – volume: 109 start-page: 228 year: 2005 end-page: 236 ident: bib28 article-title: : functional proteasomes are required for development in the vertebrate host publication-title: Exp. Parasitol. – volume: 342 start-page: 1385 year: 2013 end-page: 1389 ident: bib78 article-title: Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites publication-title: Science – volume: 1 start-page: 85 year: 2012 end-page: 93 ident: bib72 article-title: Calcium channels of schistosomes: unresolved questions and unexpected answers publication-title: Wiley Interdiscipl. Rev. Membr. Transp. Signal. – volume: 202 start-page: 29 year: 2015 end-page: 37 ident: bib46 article-title: A constitutively active G protein-coupled acetylcholine receptor regulates motility of larval publication-title: Mol. Biochem. Parasitol. – volume: 12 start-page: 493 year: 2019 ident: bib44 article-title: Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery publication-title: Parasites Vectors – volume: 5 start-page: 1802 year: 2019 end-page: 1812 ident: bib7 article-title: The proteasome as a drug target in the metazoan pathogen, publication-title: ACS Infect. Dis. – volume: 4 start-page: 40 year: 2015 ident: bib42 article-title: High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis publication-title: Infect Dis Poverty – volume: 26 start-page: 656 year: 1966 end-page: 665 ident: bib5 article-title: The possible role of acetylcholine in publication-title: Br. J. Pharmacol. Chemother. – volume: 164 start-page: 57 year: 2009 end-page: 65 ident: bib2 article-title: Towards an understanding of the mechanism of action of praziquantel publication-title: Mol. Biochem. Parasitol. – volume: 88 start-page: 583 year: 2002 end-page: 586 ident: bib31 article-title: Codon optimization improves heterologous expression of a publication-title: Parasitol. Res. – volume: 12 year: 2017 ident: bib54 article-title: Effects of proteasome inhibitor MG-132 on the parasite publication-title: PloS One – volume: 191 start-page: 189 year: 2006 end-page: 195 ident: bib71 article-title: Hypertensive effect of calcilytic NPS 2143 administration in rats publication-title: J. Endocrinol. – volume: 225 start-page: 94 year: 2018 end-page: 102 ident: bib22 article-title: Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target publication-title: Mol. Biochem. Parasitol. – volume: 6 start-page: 253 year: 2008 end-page: 258 ident: bib79 article-title: Schistosomicidal activity of the antimalarial drug, mefloquine, in publication-title: Trav. Med. Infect. Dis. – volume: 7 start-page: 1176 year: 2016 end-page: 1182 ident: bib58 article-title: The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery publication-title: MedChemComm – volume: 165 start-page: 35 year: 2012 end-page: 48 ident: bib80 article-title: New concepts in calcium-sensing receptor pharmacology and signalling publication-title: Br. J. Pharmacol. – volume: 8 start-page: 975 year: 2018 ident: bib81 article-title: Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing publication-title: Sci. Rep. – volume: 12 start-page: 13 year: 2012 end-page: 28 ident: bib70 article-title: Biogenic amines and the control of neuromuscular signaling in schistosomes publication-title: Invertebr. Neurosci. – volume: 12 start-page: 14 year: 2011 ident: bib4 article-title: Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis publication-title: BMC Genom. – volume: 67 start-page: 685 year: 1973 end-page: 693 ident: bib24 article-title: Studies with the schistosomicide oxamniquine (UK-4271). II. Activity in primates publication-title: Trans. R. Soc. Trop. Med. Hyg. – volume: 2016 start-page: 9521349 year: 2016 ident: bib17 article-title: Flavonoids and sesquiterpene lactones from publication-title: Evid Based Complement Alternat Med – volume: 154 start-page: 125 year: 2007 end-page: 133 ident: bib63 article-title: Characterization of a serotonin transporter in the parasitic flatworm, publication-title: Mol. Biochem. Parasitol. – volume: 31 start-page: 1515 year: 2015 end-page: 1518 ident: bib3 article-title: The QDREC web server: determining dose-response characteristics of complex macroparasites in phenotypic drug screens publication-title: Bioinformatics – volume: 8 start-page: 550 year: 2018 end-page: 558 ident: bib50 article-title: Structure-activity profiling of alkaloid natural product pharmacophores against a publication-title: Int J Parasitol Drugs Drug Resist – volume: 13 year: 2019 ident: bib83 article-title: The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets publication-title: PLoS Neglected Trop. Dis. – volume: 168 start-page: 24 year: 2009 end-page: 33 ident: bib73 article-title: Investigation of a dopamine receptor in publication-title: Mol. Biochem. Parasitol. – volume: 276 start-page: 36873 year: 2001 end-page: 36876 ident: bib36 article-title: Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel publication-title: J. Biol. Chem. – volume: 195 start-page: 23 year: 2014 end-page: 29 ident: bib14 article-title: Schistosomiasis control: praziquantel forever? publication-title: Mol. Biochem. Parasitol. – volume: 3 start-page: e478 year: 2009 ident: bib1 article-title: Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening publication-title: PLoS Neglected Trop. Dis. – volume: 1 start-page: S3 year: 2003 end-page: 9 ident: bib13 article-title: Praziquantel publication-title: Parasitol Res 90 Supp – volume: 48 start-page: 649 year: 1973 end-page: 652 ident: bib25 article-title: Surveillance of publication-title: Bull. World Health Organ. – volume: 13 start-page: 42 year: 2014 ident: bib35 article-title: High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor publication-title: Mol. Canc. – volume: 7 year: 2018 ident: bib11 article-title: Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy publication-title: Elife – volume: 8 start-page: 8399 year: 2018 ident: bib29 article-title: Ubiquitin proteasome pathway proteins as potential drug targets in parasite publication-title: Sci. Rep. – volume: 6 year: 2012 ident: bib49 article-title: WormAssay: a novel computer application for whole-plate motion-based screening of macroscopic parasites publication-title: PLoS Neglected Trop. Dis. – volume: 10 year: 2016 ident: bib48 article-title: High throughput screening identifies novel lead compounds with activity against larval, juvenile and adult publication-title: PLoS Neglected Trop. Dis. – volume: 117 start-page: 337 year: 2007 end-page: 347 ident: bib55 article-title: The 26S proteasome in publication-title: Exp. Parasitol. – volume: 8 start-page: 624 year: 2015 ident: bib60 article-title: Fluorescence/luminescence-based markers for the assessment of publication-title: Parasites Vectors – volume: 81 start-page: 55 year: 1987 end-page: 59 ident: bib23 article-title: A review of clinical experience with oxamniquine publication-title: Trans. R. Soc. Trop. Med. Hyg. – volume: 111 start-page: 1021 year: 2003 end-page: 1028 ident: bib37 article-title: The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone publication-title: J. Clin. Invest. – volume: 299 start-page: 323 year: 2001 end-page: 331 ident: bib57 article-title: Calcilytic compounds: potent and selective Ca publication-title: J. Pharmacol. Exp. Therapeut. – volume: 61 year: 2017 ident: bib77 article-title: Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance publication-title: Antimicrob. Agents Chemother. – volume: 383 start-page: 2253 year: 2014 end-page: 2264 ident: bib15 article-title: Human schistosomiasis publication-title: Lancet – volume: 11 year: 2018 ident: bib19 article-title: Octopamine signaling in the metazoan pathogen publication-title: Dis Model Mech – volume: 8 year: 2014 ident: bib33 article-title: Orally active antischistosomal early leads identified from the open access malaria box publication-title: PLoS Neglected Trop. Dis. – volume: 6 start-page: e1523 year: 2012 ident: bib21 article-title: A novel G protein-coupled receptor of publication-title: PLoS Neglected Trop. Dis. – volume: 10 start-page: 365 year: 2017 ident: bib38 article-title: and publication-title: Parasites Vectors – volume: 4 start-page: 21 year: 2016 ident: bib75 article-title: Mechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends publication-title: Biomark Res. – volume: 287 start-page: 40232 year: 2012 end-page: 40238 ident: bib85 article-title: Glutamate-gated chloride channels publication-title: J. Biol. Chem. – volume: 40 start-page: 1395 year: 2010 end-page: 1406 ident: bib20 article-title: Histamine signalling in publication-title: Int. J. Parasitol. – volume: 15 start-page: 927 year: 2015 end-page: 940 ident: bib40 article-title: Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis publication-title: Lancet Infect. Dis. – volume: 83 start-page: 163 year: 1997 end-page: 169 ident: bib26 article-title: Assessment of the viability of publication-title: Parasitol. Res. – volume: 9 year: 2013 ident: bib84 article-title: Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII publication-title: PLoS Pathog. – volume: 88 start-page: 1 year: 2009 end-page: 22 ident: bib69 article-title: Neuronal signaling in schistosomes: current status and prospects for postgenomics publication-title: Can. J. Zool. – volume: 7 start-page: 727 year: 2015 end-page: 735 ident: bib67 article-title: Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline publication-title: Future Med. Chem. – year: 2001 ident: bib41 article-title: Schistosomiasis publication-title: Curr. Protoc. Im. – volume: 4 start-page: 254 year: 2013 end-page: 258 ident: bib18 article-title: Synthesis of novel analogs of cabergoline: improving cardiovascular safety by removing 5-HT2B receptor agonism publication-title: ACS Med. Chem. Lett. – volume: 6 year: 2012 ident: bib65 article-title: Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases publication-title: PLoS Neglected Trop. Dis. – volume: 10 year: 2014 ident: bib64 article-title: Serotonin signaling in publication-title: PLoS Pathog. – volume: 18 start-page: 315 year: 2018 end-page: 320 ident: bib66 article-title: Ubiquitin proteasome system as a potential drug target for malaria publication-title: Curr. Top. Med. Chem. – volume: 14 start-page: 461 year: 2019 end-page: 481 ident: bib43 article-title: Life cycle maintenance and drug-sensitivity assays for early drug discovery in publication-title: Nat. Protoc. – volume: 7 start-page: 25 year: 2001 end-page: 47 ident: bib8 article-title: Paroxetine: a review publication-title: CNS Drug Rev. – start-page: 1 year: 2019 end-page: 8 ident: bib82 article-title: Towards deorphanizing G protein-coupled receptors of publication-title: Parasitology – volume: 10 year: 2014 ident: bib45 article-title: Functional characterization of a novel family of acetylcholine-gated chloride channels in publication-title: PLoS Pathog. – start-page: 1 year: 2014 end-page: 29 ident: bib86 article-title: Anthelmintic drugs and nematicides: studies in publication-title: WormBook. pp. – start-page: 1 year: 2007 end-page: 13 ident: bib32 article-title: Anthelmintic Drugs. WormBook – volume: 3 start-page: e504 year: 2009 ident: bib52 article-title: Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of publication-title: PLoS Neglected Trop. Dis. – volume: 69 start-page: 863 year: 2014 end-page: 870 ident: bib59 article-title: The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and publication-title: J. Antimicrob. Chemother. – volume: 18 start-page: 7900 year: 2010 end-page: 7910 ident: bib39 article-title: Identification by high-throughput screening of inhibitors of publication-title: Bioorg. Med. Chem. – volume: 294 start-page: 18873 year: 2019 end-page: 18880 ident: bib62 article-title: The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel publication-title: J. Biol. Chem. – volume: 32 start-page: 83 year: 1983 end-page: 93 ident: bib51 article-title: Neuropharmacology of the parasitic trematode, publication-title: Am. J. Trop. Med. Hyg. – volume: 10 year: 2014 ident: bib10 article-title: Death and axes": unexpected Ca publication-title: PLoS Pathog. – volume: 9 year: 2015 ident: bib61 article-title: Activity profile of an FDA-approved compound library against publication-title: PLoS Neglected Trop. Dis. – volume: 8 start-page: 229 year: 2012 end-page: 259 ident: bib56 article-title: Cross-genome clustering of human and publication-title: Evol Bioinform Online – volume: 27 start-page: 676 year: 2020 end-page: 696 ident: bib76 article-title: The mechanism of action of praziquantel: can new drugs exploit similar mechanisms? publication-title: Curr. Med. Chem. – volume: 9 year: 2015 ident: bib9 article-title: Ergot alkaloids (re)generate new leads as antiparasitics publication-title: PLoS Neglected Trop. Dis. – volume: 12 year: 2016 ident: bib12 article-title: A miniaturized screen of a publication-title: PLoS Pathog. – volume: 63 start-page: 9987 year: 2015 end-page: 9995 ident: bib53 article-title: Calcium-sensing receptor (CaSR)-mediated anti-inflammatory effects of L-amino acids in intestinal epithelial cells publication-title: J. Agric. Food Chem. – volume: 284 start-page: 1503 year: 2017 end-page: 1517 ident: bib6 article-title: Targeting proteasomes in infectious organisms to combat disease publication-title: FEBS J. – volume: 13 start-page: 2374 year: 2018 end-page: 2389 ident: bib47 article-title: Chemotherapy for fighting schistosomiasis: past, present and future publication-title: ChemMedChem – start-page: 171 year: 2015 end-page: 189 ident: bib68 article-title: Functional genomics of serotonin receptors in helminth parasites: elucidation of receptor function through RNA interference (RNAi) publication-title: Serotonin Receptor Technologies – volume: 119 start-page: 75 year: 2002 end-page: 86 ident: bib30 article-title: A novel publication-title: Mol. Biochem. Parasitol. – volume: 8 year: 2019 ident: bib34 article-title: Programmed genome editing of the omega-1 ribonuclease of the blood fluke, publication-title: eLife – volume: 52 start-page: 129 year: 1977 ident: 10.1016/j.ijpddr.2020.05.002_bib27 article-title: Praziquantel, a new broad-spectrum antischistosomal agent publication-title: Zeitschrift fur Parasitenkunde (Berlin, Germany) doi: 10.1007/BF00389899 – volume: 4 start-page: 40 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib42 article-title: High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis publication-title: Infect Dis Poverty doi: 10.1186/s40249-015-0071-z – volume: 342 start-page: 1385 year: 2013 ident: 10.1016/j.ijpddr.2020.05.002_bib78 article-title: Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites publication-title: Science doi: 10.1126/science.1243106 – volume: 284 start-page: 1503 year: 2017 ident: 10.1016/j.ijpddr.2020.05.002_bib6 article-title: Targeting proteasomes in infectious organisms to combat disease publication-title: FEBS J. doi: 10.1111/febs.14029 – volume: 83 start-page: 163 year: 1997 ident: 10.1016/j.ijpddr.2020.05.002_bib26 article-title: Assessment of the viability of Schistosoma mansoni schistosomula by comparative uptake of various vital dyes publication-title: Parasitol. Res. doi: 10.1007/s004360050227 – volume: 40 start-page: 1395 year: 2010 ident: 10.1016/j.ijpddr.2020.05.002_bib20 article-title: Histamine signalling in Schistosoma mansoni: immunolocalisation and characterisation of a new histamine-responsive receptor (SmGPR-2) publication-title: Int. J. Parasitol. doi: 10.1016/j.ijpara.2010.04.006 – volume: 18 start-page: 315 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib66 article-title: Ubiquitin proteasome system as a potential drug target for malaria publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026618666180427145308 – volume: 6 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib49 article-title: WormAssay: a novel computer application for whole-plate motion-based screening of macroscopic parasites publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0001494 – volume: 27 start-page: 676 year: 2020 ident: 10.1016/j.ijpddr.2020.05.002_bib76 article-title: The mechanism of action of praziquantel: can new drugs exploit similar mechanisms? publication-title: Curr. Med. Chem. doi: 10.2174/0929867325666180926145537 – volume: 11 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib19 article-title: Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development publication-title: Dis Model Mech doi: 10.1242/dmm.033563 – volume: 88 start-page: 583 year: 2002 ident: 10.1016/j.ijpddr.2020.05.002_bib31 article-title: Codon optimization improves heterologous expression of a Schistosoma mansoni cDNA in HEK293 cells publication-title: Parasitol. Res. doi: 10.1007/s00436-001-0585-0 – volume: 1 start-page: 85 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib72 article-title: Calcium channels of schistosomes: unresolved questions and unexpected answers publication-title: Wiley Interdiscipl. Rev. Membr. Transp. Signal. doi: 10.1002/wmts.19 – volume: 3 start-page: e478 year: 2009 ident: 10.1016/j.ijpddr.2020.05.002_bib1 article-title: Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0000478 – volume: 1 start-page: S3 year: 2003 ident: 10.1016/j.ijpddr.2020.05.002_bib13 article-title: Praziquantel publication-title: Parasitol Res 90 Supp doi: 10.1007/s00436-002-0751-z – volume: 8 start-page: 8399 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib29 article-title: Ubiquitin proteasome pathway proteins as potential drug targets in parasite Trypanosoma cruzi publication-title: Sci. Rep. doi: 10.1038/s41598-018-26532-z – volume: 67 start-page: 685 year: 1973 ident: 10.1016/j.ijpddr.2020.05.002_bib24 article-title: Studies with the schistosomicide oxamniquine (UK-4271). II. Activity in primates publication-title: Trans. R. Soc. Trop. Med. Hyg. doi: 10.1016/0035-9203(73)90039-4 – volume: 7 start-page: 1176 year: 2016 ident: 10.1016/j.ijpddr.2020.05.002_bib58 article-title: The antidepressant drug paroxetine as a new lead candidate in schistosome drug discovery publication-title: MedChemComm doi: 10.1039/C5MD00596E – volume: 10 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib64 article-title: Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003878 – start-page: 1 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib86 article-title: Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans publication-title: WormBook. pp. – volume: 117 start-page: 337 year: 2007 ident: 10.1016/j.ijpddr.2020.05.002_bib55 article-title: The 26S proteasome in Schistosoma mansoni: bioinformatics analysis, developmental expression, and RNA interference (RNAi) studies publication-title: Exp. Parasitol. doi: 10.1016/j.exppara.2007.08.002 – volume: 6 start-page: e1523 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib21 article-title: A novel G protein-coupled receptor of Schistosoma mansoni (SmGPR-3) is activated by dopamine and is widely expressed in the nervous system publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0001523 – volume: 383 start-page: 2253 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib15 article-title: Human schistosomiasis publication-title: Lancet doi: 10.1016/S0140-6736(13)61949-2 – volume: 9 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib61 article-title: Activity profile of an FDA-approved compound library against Schistosoma mansoni publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0003962 – volume: 88 start-page: 1 year: 2009 ident: 10.1016/j.ijpddr.2020.05.002_bib69 article-title: Neuronal signaling in schistosomes: current status and prospects for postgenomics publication-title: Can. J. Zool. doi: 10.1139/Z09-126 – volume: 8 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib33 article-title: Orally active antischistosomal early leads identified from the open access malaria box publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0002610 – volume: 9 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib9 article-title: Ergot alkaloids (re)generate new leads as antiparasitics publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0004063 – volume: 164 start-page: 57 year: 2009 ident: 10.1016/j.ijpddr.2020.05.002_bib2 article-title: Towards an understanding of the mechanism of action of praziquantel publication-title: Mol. Biochem. Parasitol. doi: 10.1016/j.molbiopara.2008.11.007 – volume: 6 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib65 article-title: Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0001762 – volume: 61 year: 2017 ident: 10.1016/j.ijpddr.2020.05.002_bib77 article-title: Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.02582-16 – volume: 13 year: 2019 ident: 10.1016/j.ijpddr.2020.05.002_bib83 article-title: The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0007693 – volume: 81 start-page: 55 year: 1987 ident: 10.1016/j.ijpddr.2020.05.002_bib23 article-title: A review of clinical experience with oxamniquine publication-title: Trans. R. Soc. Trop. Med. Hyg. doi: 10.1016/0035-9203(87)90282-3 – volume: 7 start-page: 727 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib67 article-title: Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline publication-title: Future Med. Chem. doi: 10.4155/fmc.15.26 – volume: 5 start-page: 1802 year: 2019 ident: 10.1016/j.ijpddr.2020.05.002_bib7 article-title: The proteasome as a drug target in the metazoan pathogen, Schistosoma mansoni publication-title: ACS Infect. Dis. doi: 10.1021/acsinfecdis.9b00237 – volume: 109 start-page: 228 year: 2005 ident: 10.1016/j.ijpddr.2020.05.002_bib28 article-title: Schistosoma mansoni: functional proteasomes are required for development in the vertebrate host publication-title: Exp. Parasitol. doi: 10.1016/j.exppara.2005.01.002 – volume: 168 start-page: 24 year: 2009 ident: 10.1016/j.ijpddr.2020.05.002_bib73 article-title: Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization publication-title: Mol. Biochem. Parasitol. doi: 10.1016/j.molbiopara.2009.06.003 – volume: 8 year: 2019 ident: 10.1016/j.ijpddr.2020.05.002_bib34 article-title: Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni publication-title: eLife doi: 10.7554/eLife.41337 – volume: 8 start-page: 550 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib50 article-title: Structure-activity profiling of alkaloid natural product pharmacophores against a Schistosoma serotonin receptor publication-title: Int J Parasitol Drugs Drug Resist doi: 10.1016/j.ijpddr.2018.09.001 – volume: 294 start-page: 18873 year: 2019 ident: 10.1016/j.ijpddr.2020.05.002_bib62 article-title: The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel publication-title: J. Biol. Chem. doi: 10.1074/jbc.AC119.011093 – start-page: 1 year: 2007 ident: 10.1016/j.ijpddr.2020.05.002_bib32 – volume: 69 start-page: 863 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib59 article-title: The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer) publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkt491 – year: 2001 ident: 10.1016/j.ijpddr.2020.05.002_bib41 article-title: Schistosomiasis publication-title: Curr. Protoc. Im. – volume: 12 start-page: 14 year: 2011 ident: 10.1016/j.ijpddr.2020.05.002_bib4 article-title: Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis publication-title: BMC Genom. doi: 10.1186/1471-2164-12-14 – volume: 4 start-page: 254 year: 2013 ident: 10.1016/j.ijpddr.2020.05.002_bib18 article-title: Synthesis of novel analogs of cabergoline: improving cardiovascular safety by removing 5-HT2B receptor agonism publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml3003814 – volume: 4 start-page: 21 year: 2016 ident: 10.1016/j.ijpddr.2020.05.002_bib75 article-title: Mechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends publication-title: Biomark Res. doi: 10.1186/s40364-016-0075-2 – volume: 12 year: 2016 ident: 10.1016/j.ijpddr.2020.05.002_bib12 article-title: A miniaturized screen of a Schistosoma mansoni serotonergic G protein-coupled receptor identifies novel classes of parasite-selective inhibitors publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1005651 – volume: 276 start-page: 36873 year: 2001 ident: 10.1016/j.ijpddr.2020.05.002_bib36 article-title: Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel publication-title: J. Biol. Chem. doi: 10.1074/jbc.C100273200 – volume: 13 start-page: 42 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib35 article-title: High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor publication-title: Mol. Canc. doi: 10.1186/1476-4598-13-42 – volume: 111 start-page: 1021 year: 2003 ident: 10.1016/j.ijpddr.2020.05.002_bib37 article-title: The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone publication-title: J. Clin. Invest. doi: 10.1172/JCI17416 – start-page: 171 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib68 article-title: Functional genomics of serotonin receptors in helminth parasites: elucidation of receptor function through RNA interference (RNAi) – volume: 18 start-page: 7900 year: 2010 ident: 10.1016/j.ijpddr.2020.05.002_bib39 article-title: Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2010.09.041 – volume: 165 start-page: 35 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib80 article-title: New concepts in calcium-sensing receptor pharmacology and signalling publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2011.01511.x – volume: 12 start-page: 493 year: 2019 ident: 10.1016/j.ijpddr.2020.05.002_bib44 article-title: Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery publication-title: Parasites Vectors doi: 10.1186/s13071-019-3747-6 – volume: 10 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib45 article-title: Functional characterization of a novel family of acetylcholine-gated chloride channels in Schistosoma mansoni publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1004181 – volume: 176 start-page: 42 year: 2011 ident: 10.1016/j.ijpddr.2020.05.002_bib74 article-title: Glutamate-mediated signaling in Schistosoma mansoni: a novel glutamate receptor is expressed in neurons and the female reproductive tract publication-title: Mol. Biochem. Parasitol. doi: 10.1016/j.molbiopara.2010.12.001 – volume: 195 start-page: 23 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib14 article-title: Schistosomiasis control: praziquantel forever? publication-title: Mol. Biochem. Parasitol. doi: 10.1016/j.molbiopara.2014.06.002 – volume: 7 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib11 article-title: Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy publication-title: Elife doi: 10.7554/eLife.35755 – volume: 113 start-page: 55 year: 1996 ident: 10.1016/j.ijpddr.2020.05.002_bib16 article-title: Cholinergic inhibition of muscle fibres isolated from Schistosoma mansoni (Trematoda:Digenea) publication-title: Parasitology doi: 10.1017/S0031182000066270 – volume: 3 start-page: e504 year: 2009 ident: 10.1016/j.ijpddr.2020.05.002_bib52 article-title: Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0000504 – volume: 8 start-page: 975 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib81 article-title: Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing publication-title: Sci. Rep. doi: 10.1038/s41598-017-18457-w – volume: 10 year: 2014 ident: 10.1016/j.ijpddr.2020.05.002_bib10 article-title: Death and axes": unexpected Ca2+ entry phenologs predict new anti-schistosomal agents publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003942 – volume: 14 start-page: 461 year: 2019 ident: 10.1016/j.ijpddr.2020.05.002_bib43 article-title: Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni publication-title: Nat. Protoc. doi: 10.1038/s41596-018-0101-y – volume: 2016 start-page: 9521349 year: 2016 ident: 10.1016/j.ijpddr.2020.05.002_bib17 article-title: Flavonoids and sesquiterpene lactones from Artemisia absinthium and Tanacetum parthenium against Schistosoma mansoni worms publication-title: Evid Based Complement Alternat Med doi: 10.1155/2016/9521349 – volume: 10 start-page: 365 year: 2017 ident: 10.1016/j.ijpddr.2020.05.002_bib38 article-title: In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium publication-title: Parasites Vectors doi: 10.1186/s13071-017-2293-3 – volume: 63 start-page: 9987 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib53 article-title: Calcium-sensing receptor (CaSR)-mediated anti-inflammatory effects of L-amino acids in intestinal epithelial cells publication-title: J. Agric. Food Chem. doi: 10.1021/acs.jafc.5b03749 – volume: 7 start-page: 25 year: 2001 ident: 10.1016/j.ijpddr.2020.05.002_bib8 article-title: Paroxetine: a review publication-title: CNS Drug Rev. doi: 10.1111/j.1527-3458.2001.tb00189.x – volume: 225 start-page: 94 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib22 article-title: Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target publication-title: Mol. Biochem. Parasitol. doi: 10.1016/j.molbiopara.2018.09.004 – volume: 31 start-page: 1515 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib3 article-title: The QDREC web server: determining dose-response characteristics of complex macroparasites in phenotypic drug screens publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu831 – volume: 15 start-page: 927 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib40 article-title: Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(15)00066-3 – volume: 6 start-page: 253 year: 2008 ident: 10.1016/j.ijpddr.2020.05.002_bib79 article-title: Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice publication-title: Trav. Med. Infect. Dis. doi: 10.1016/j.tmaid.2008.06.006 – volume: 299 start-page: 323 year: 2001 ident: 10.1016/j.ijpddr.2020.05.002_bib57 article-title: Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone publication-title: J. Pharmacol. Exp. Therapeut. doi: 10.1016/S0022-3565(24)29333-2 – volume: 12 year: 2017 ident: 10.1016/j.ijpddr.2020.05.002_bib54 article-title: Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni publication-title: PloS One doi: 10.1371/journal.pone.0184192 – volume: 10 year: 2016 ident: 10.1016/j.ijpddr.2020.05.002_bib48 article-title: High throughput screening identifies novel lead compounds with activity against larval, juvenile and adult Schistosoma mansoni publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0004659 – volume: 13 start-page: 2374 year: 2018 ident: 10.1016/j.ijpddr.2020.05.002_bib47 article-title: Chemotherapy for fighting schistosomiasis: past, present and future publication-title: ChemMedChem doi: 10.1002/cmdc.201800572 – volume: 32 start-page: 83 year: 1983 ident: 10.1016/j.ijpddr.2020.05.002_bib51 article-title: Neuropharmacology of the parasitic trematode, Schistosoma mansoni publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.1983.32.83 – volume: 191 start-page: 189 year: 2006 ident: 10.1016/j.ijpddr.2020.05.002_bib71 article-title: Hypertensive effect of calcilytic NPS 2143 administration in rats publication-title: J. Endocrinol. doi: 10.1677/joe.1.06924 – volume: 119 start-page: 75 year: 2002 ident: 10.1016/j.ijpddr.2020.05.002_bib30 article-title: A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine publication-title: Mol. Biochem. Parasitol. doi: 10.1016/S0166-6851(01)00400-5 – volume: 8 start-page: 229 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib56 article-title: Cross-genome clustering of human and C. elegans G-protein coupled receptors publication-title: Evol Bioinform Online doi: 10.4137/EBO.S9405 – volume: 8 start-page: 624 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib60 article-title: Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays publication-title: Parasites Vectors doi: 10.1186/s13071-015-1233-3 – volume: 202 start-page: 29 year: 2015 ident: 10.1016/j.ijpddr.2020.05.002_bib46 article-title: A constitutively active G protein-coupled acetylcholine receptor regulates motility of larval Schistosoma mansoni publication-title: Mol. Biochem. Parasitol. doi: 10.1016/j.molbiopara.2015.09.001 – start-page: 1 year: 2019 ident: 10.1016/j.ijpddr.2020.05.002_bib82 article-title: Towards deorphanizing G protein-coupled receptors of Schistosoma mansoni using the MALAR yeast two-hybrid system publication-title: Parasitology – volume: 287 start-page: 40232 issue: 48 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib85 article-title: Glutamate-gated chloride channels publication-title: J. Biol. Chem. doi: 10.1074/jbc.R112.406280 – volume: 9 year: 2013 ident: 10.1016/j.ijpddr.2020.05.002_bib84 article-title: Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1003254 – volume: 154 start-page: 125 year: 2007 ident: 10.1016/j.ijpddr.2020.05.002_bib63 article-title: Characterization of a serotonin transporter in the parasitic flatworm, Schistosoma mansoni: cloning, expression and functional analysis publication-title: Mol. Biochem. Parasitol. doi: 10.1016/j.molbiopara.2007.03.010 – volume: 12 start-page: 13 year: 2012 ident: 10.1016/j.ijpddr.2020.05.002_bib70 article-title: Biogenic amines and the control of neuromuscular signaling in schistosomes publication-title: Invertebr. Neurosci. doi: 10.1007/s10158-012-0132-y – volume: 26 start-page: 656 year: 1966 ident: 10.1016/j.ijpddr.2020.05.002_bib5 article-title: The possible role of acetylcholine in Schistosoma mansoni publication-title: Br. J. Pharmacol. Chemother. doi: 10.1111/j.1476-5381.1966.tb01845.x – volume: 48 start-page: 649 year: 1973 ident: 10.1016/j.ijpddr.2020.05.002_bib25 article-title: Surveillance of Echinococcus granulosus in dogs with arecoline hydrobromide publication-title: Bull. World Health Organ. |
| SSID | ssj0000601810 |
| Score | 2.2470057 |
| Snippet | Neglected tropical diseases are of growing worldwide concern and schistosomiasis, caused by parasitic flatworms, continues to be a major threat with more than... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 73 |
| SubjectTerms | Animals Anthelmintic Drug Evaluation, Preclinical Drug Repositioning GPCR Humans Motility NPS-2143 Receptors, G-Protein-Coupled - drug effects Schistosoma mansoni - drug effects Schistosomiasis Schistosomiasis mansoni - drug therapy Schistosomicides - chemistry Schistosomicides - pharmacology Screening |
| Title | Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni |
| URI | https://dx.doi.org/10.1016/j.ijpddr.2020.05.002 https://www.ncbi.nlm.nih.gov/pubmed/32531750 https://www.proquest.com/docview/2412994148 https://pubmed.ncbi.nlm.nih.gov/PMC7284125 https://doaj.org/article/ae57b753674642aabd8528e70e77631a |
| Volume | 13 |
| WOSCitedRecordID | wos000556674900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2211-3207 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000601810 issn: 2211-3207 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3LT9wwEIctilDVC-qDx_aBXKnXgHFw7BzbqqiXokpQaW-WnyLAJmg327-fGTtZ7ZbDXnrNOpvYM7Y_O-PfEPLFytLFKrhCOethgcJUYYADCiUiCr6Z0jqTkk3Iqys1nda_11J9YUxYlgfODXdmgpAWmLqSF4DKxlivBFdBsiCha5wnNGKyXltM5TEYhahwg4Vz1OmDIuO5uRTc1dw9eo9yoJydru2qjPNSku_fmJ6e4-e_UZRr09Lla7I_8CT9muvxhuyE9i15-Wv4Yv6O3OeTuHHYmqNdpKZtO0RMT23TmTTe0VnOkhsWtL81PcWzk82cYqAeYjreBaBIU5Q7jQ_L-0CvXZIqXnQzQ2cGj5A1B-TP5Y-b7z-LIcFC4QSv-8LKyhnLTLQqlixWYJoooY1Dzbj3rLLO8ZpHnOOZB7JRoRZW8MoqADNrbXlIdtuuDceEeujn3FtYYF7A2AuFwdbOVQpwU9SWnU9IOTavdoP6OCbBeNBjmNmdzkbRaBTNhAajTEixuusxq29sKf8NLbcqi9rZ6QJ4lB48Sm_zqAmRo931gCEZL-Cvmi2P_zy6iYZeip9eTBu65UIDJ8G8D02jJuQou83qJUsuEOIYPHfDoTZqsflL29wmJXAJcAGE-v5_VPsDeYVVycGNH8luP1-GT2TP_e2bxfyEvJBTdZI62RNi4SsO |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+annotated+bioactive+molecules+that+impair+motility+of+the+blood+fluke+Schistosoma+mansoni&rft.jtitle=International+journal+for+parasitology+--+drugs+and+drug+resistance&rft.au=Duguet%2C+Thomas+B&rft.au=Glebov%2C+Anastasia&rft.au=Hussain%2C+Asimah&rft.au=Kulkarni%2C+Shashank&rft.date=2020-08-01&rft.eissn=2211-3207&rft.volume=13&rft.spage=73&rft_id=info:doi/10.1016%2Fj.ijpddr.2020.05.002&rft_id=info%3Apmid%2F32531750&rft.externalDocID=32531750 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-3207&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-3207&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-3207&client=summon |